Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03740100
What this trial is testing

Single-arm Study With Bimiralisib in Patients With HNSCC Harboring NOTCH1 Loss of Function Mutations

Who this might be right for
HNSCC
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Ended earlyNCT01015664
What this trial is testing

Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Tennessee Cancer Institute 11
Testing effectiveness (Phase 2)Looking for participantsNCT06194656
What this trial is testing

Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Shanghai Institute Of Biological Products 81
Testing effectiveness (Phase 2)Study completedNCT02718820
What this trial is testing

Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Carcinoma
Medical University of Vienna 22
Early research (Phase 1)Looking for participantsNCT06465069
What this trial is testing

LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 420
Testing effectiveness (Phase 2)Study completedNCT01458392
What this trial is testing

Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT06508606
What this trial is testing

AK117 (Anti-CD47 mAb) Plus Cetuximab or AK104 (Anti-PD-1/CTLA-4 bsAb) as Second-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
West China Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00015964
What this trial is testing

ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck

Who this might be right for
Head and Neck Cancer
University of Chicago 51
Testing effectiveness (Phase 2)Study completedNCT00005087
What this trial is testing

Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 105
Large-scale testing (Phase 3)Looking for participantsNCT07276399
What this trial is testing

Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Janssen Research & Development, LLC 500
Testing effectiveness (Phase 2)Ended earlyNCT00591149
What this trial is testing

Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer

Who this might be right for
Head and Neck CancerCarcinoma, Squamous
University of Kansas Medical Center 16
Testing effectiveness (Phase 2)Study completedNCT00753038
What this trial is testing

Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma

Who this might be right for
Carcinoma, Squamous Cell of the Head and Neck
Oncolytics Biotech 14
Testing effectiveness (Phase 2)UnknownNCT04399785
What this trial is testing

Phase II Study for Combination of Camrelizumab and SBRT in the First-line Treatment for R/M HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Xingchen Peng 34
Testing effectiveness (Phase 2)Study completedNCT05721443
What this trial is testing

Cetuximab Plus Dalpicilib in Patients With HPV Negative, PD-1 Resistant R/M HNSCC

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07361133
What this trial is testing

Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer

Who this might be right for
Squamous Cell CarcinomaAdvanced Head and Neck Cancer
National Cancer Institute, Egypt 120
Testing effectiveness (Phase 2)Ended earlyNCT00216138
What this trial is testing

Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck

Who this might be right for
Head and Neck Cancer
Hoosier Cancer Research Network 19
Early research (Phase 1)WithdrawnNCT05472506
What this trial is testing

Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck CancerHead Cancer+3 more
Ikena Oncology
Early research (Phase 1)Study completedNCT00019110
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

Who this might be right for
Anal CancerCervical CancerEsophageal Cancer+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT05287113
What this trial is testing

Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Incyte Biosciences International Sàrl 176
Testing effectiveness (Phase 2)Active Not RecruitingNCT06062420
What this trial is testing

A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202

Who this might be right for
Neoplasms, Head and Neck
GlaxoSmithKline 316
Next Page